Champions Oncology, Inc. (CSBR)
4.94
+0.06
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
5.17
+0.23
(+4.66%)
After-Hours: 20:00
Champions Oncology Net Income (Quarterly) : -0.426M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.426M |
| April 30, 2026 | -0.667M |
| January 31, 2026 | -0.279M |
| October 31, 2025 | 0.237M |
| July 31, 2025 | -0.466M |
| April 30, 2025 | -1.835M |
| January 31, 2025 | 4.495M |
| October 31, 2024 | 0.728M |
| July 31, 2024 | 1.313M |
| April 30, 2024 | -0.109M |
| January 31, 2024 | -2.53M |
| October 31, 2023 | -2.071M |
| July 31, 2023 | -2.566M |
| April 30, 2023 | -2.561M |
| January 31, 2023 | -2.439M |
| October 31, 2022 | -0.016M |
| July 31, 2022 | -0.319M |
| April 30, 2022 | -0.344M |
| January 31, 2022 | 0.787M |
| October 31, 2021 | 0.277M |
| July 31, 2021 | -0.172M |
| April 30, 2021 | -0.481M |
| January 31, 2021 | 0.959M |
| October 31, 2020 | 0.001M |
| July 31, 2020 | 0.075M |
| Date | Value |
|---|---|
| April 30, 2020 | -2.116M |
| January 31, 2020 | 0.407M |
| October 31, 2019 | 0.307M |
| July 31, 2019 | -0.641M |
| April 30, 2019 | -0.252M |
| January 31, 2019 | -0.369M |
| October 31, 2018 | 0.267M |
| July 31, 2018 | 0.482M |
| April 30, 2018 | -0.662M |
| January 31, 2018 | -0.076M |
| October 31, 2017 | -0.094M |
| July 31, 2017 | -0.674M |
| April 30, 2017 | -2.424M |
| January 31, 2017 | -1.409M |
| October 31, 2016 | -0.504M |
| July 31, 2016 | -2.546M |
| April 30, 2016 | -2.574M |
| January 31, 2016 | -2.412M |
| October 31, 2015 | -2.548M |
| July 31, 2015 | -2.913M |
| April 30, 2015 | -3.677M |
| January 31, 2015 | -2.816M |
| October 31, 2014 | -3.078M |
| July 31, 2014 | -3.548M |
| April 30, 2014 | -2.272M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 121.36M |
| Avantor, Inc. | 38.10M |
| Personalis, Inc. | -31.68M |
| Adaptive Biotechnologies Corp. | -39.94M |
| 10X Genomics, Inc. | -17.93M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 15.23M |
| Total Expenses (Quarterly) | 15.66M |
| EPS Diluted (Quarterly) | -0.0306 |
| Enterprise Value | 75.94M |
| Gross Profit Margin (Quarterly) | 48.48% |
| Profit Margin (Quarterly) | -2.80% |
| Earnings Yield | -1.62% |
| Normalized Earnings Yield | -1.624 |